Global Drug Discovery Technologies Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Drug Discovery Technologies Market Insights, Forecast to 2034
This report mainly focuses on drug discovery technologies marekt. Current drug discovery technologies aims to discover all the modern techniques and technologies used in drug discovery.
Market Analysis and InsightsGlobal Drug Discovery Technologies Market
Global Drug Discovery Technologies market is expected to reach to US$ 51640 million in 2023, with a positive growth of %, compared with US$ 48000 million in 2022. Backed with the increasing demand from downstream industries, Drug Discovery Technologies industry is evaluated to reach US$ 76370 million in 2033. The CAGR will be 6.7% during 2023 to 2033.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
Report Covers
This report presents an overview of global Drug Discovery Technologies market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Drug Discovery Technologies market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Segment by Type
Small-molecule Drugs
Biologics
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drug Discovery Technologies introduction, etc. Drug Discovery Technologies Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Drug Discovery Technologies
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Drug Discovery Technologies Market
Global Drug Discovery Technologies market is expected to reach to US$ 51640 million in 2023, with a positive growth of %, compared with US$ 48000 million in 2022. Backed with the increasing demand from downstream industries, Drug Discovery Technologies industry is evaluated to reach US$ 76370 million in 2033. The CAGR will be 6.7% during 2023 to 2033.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
Report Covers
This report presents an overview of global Drug Discovery Technologies market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Drug Discovery Technologies market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Segment by Type
Small-molecule Drugs
Biologics
Segment by Application
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drug Discovery Technologies introduction, etc. Drug Discovery Technologies Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Drug Discovery Technologies
Chapter 13Methodology and Data Sources adopted by MRAResearch